通用幹細胞* (7607.TW) 2025Q2 financial report shows cash of 30.94M TWD, total debt of 0 TWD, with cash clearly exceeding total debt. This indicates the company is cash-rich and has a sound financial structure, facing almost no short-term debt pressure and enjoying very comfortable liquidity. Such situations are common for companies with profitable core businesses and strong cash flow. It is recommended to also monitor cash flow structure, capital expenditures, changes in debt, and compare with peers. With Growin AI Value Analysis, confirm whether the cash advantage is being used to create value for the company. If the company can use this cash to drive growth or improve shareholder returns, investor confidence will be further strengthened.